Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison (Q104073829)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

title

Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

1 reference

Ioanna-Evdokia Galani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

Vasiliki Triantafyllia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

Paraskevi C. Fragkou

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

author name string

Nikoletta Rovina

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

Vicky Lampropoulou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

Maria Manioudaki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

Eleftherios Pavlos

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

Evangelia Koukaki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

Vasiliki Panou

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

Vasiliki Rapti

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

Ourania Koltsida

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

Andreas Mentis

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

Nikolaos Koulouris

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

Sotirios Tsiodras

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

Antonia Koutsoukou

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

Evangelos Andreakos

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

publication date

4 December 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

cites work

Viruses and interferons

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Type I interferons in infectious disease

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Clinical Characteristics of Coronavirus Disease 2019 in China

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Virological assessment of hospitalized patients with COVID-2019

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

The pathology of influenza virus infections

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

1 reference

7 January 2021

Incubation periods of acute respiratory viral infections: a systematic review.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

COVID-19: consider cytokine storm syndromes and immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Pathogenic potential of interferon αβ in acute influenza infection

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Operational considerations for case management of COVID-19 in health facility and community. Interim guidance

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Inflammasome Complexes: Emerging Mechanisms and Effector Functions

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Neutrophils in viral infections: Current concepts and caveats

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Cytokine Storms: Understanding COVID-19

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Clinical and immunological features of severe and moderate coronavirus disease 2019

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

The role of interleukin-6 in monitoring severe case of coronavirus disease 2019

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice.

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Type III interferons disrupt the lung epithelial barrier upon viral recognition

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Type I and III interferons disrupt lung epithelial repair during recovery from viral infection

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

The yin and yang of viruses and interferons

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b Accessory Proteins during MERS Coronavirus Infection

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Viral dynamics in mild and severe cases of COVID-19

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Temporal dynamics in viral shedding and transmissibility of COVID-19

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Diagnosis and Treatment Plan for COVID-19 (Trial Version 6)

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

1 reference

https://api.crossref.org/works/10.1038%2FS41590-020-00840-X

7 January 2021

10.1038/S41590-020-00840-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33277638%20AND%20SRC:MED&resulttype=core&format=json

9 December 2020

1 reference